Delta FosB and AP-1-mediated transcription modulate cannabinoid CB1 receptor signaling and desensitization in striatal and limbic brain regions

Biochemical Pharmacology

Volumn 91, Issue 3, 2014, Pages 380-389

  Lazenka, Matthew F ^a   David, Bethany G ^a   Lichtman, Aron H ^a   Nestler, Eric J ^b   Selley, Dana E ^a   Sim Selley, Laura J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DRONABINOL; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR DELTA FOSB; CANNABINOID RECEPTOR AGONIST; FOSB PROTEIN, MOUSE; PROTEIN C FOS;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; GENE ACTIVATION; GENE INDUCTION; GENE OVEREXPRESSION; IN VIVO CULTURE; LIMBIC SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PUTAMEN; SUBSTANTIA NIGRA; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; VENTRAL TEGMENTUM; ANIMAL; DRUG EFFECTS; DRUG TOLERANCE; GENETICS; MALE; METABOLISM; ONCOGENE;

ANIMALS; CANNABINOID RECEPTOR AGONISTS; CORPUS STRIATUM; DRONABINOL; DRUG TOLERANCE; GENES, JUN; GTP-BINDING PROTEINS; LIMBIC SYSTEM; MALE; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, CANNABINOID, CB1; TRANSCRIPTION FACTOR AP-1;

EID: 84925696396     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.07.024     Document Type: Article

References (50)

1. M. Rinaldi-Carmona, F. Barth, M. Heaulme, D. Shire, B. Calandra, and C. Congy SR141716A, a potent and selective antagonist of the brain cannabinoid receptor FEBS Lett 350 1994 240 244
2. A. Zimmer, A.M. Zimmer, A.G. Hohmann, M. Herkenham, and T.I. Bonner Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice Proc Natl Acad Sci USA 96 1999 5780 5785
3. L.J. Sim-Selley Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids Crit Rev Neurobiol 15 2003 91 119
4. A.H. Lichtman, and B.R. Martin Cannabinoid tolerance and dependence Handb Exp Pharmacol 2005 691 717
5. D.L. McKinney, M.P. Cassidy, L.M. Collier, B.R. Martin, J.L. Wiley, and D.E. Selley Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol J Pharmacol Exp Ther 324 2008 664 673
6. L.J. Sim-Selley, N.S. Schechter, W.K. Rorrer, G.D. Dalton, J. Hernandez, and B.R. Martin Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration Mol Pharmacol 70 2006 986 996
7. J. Hirvonen, R.S. Goodwin, C.T. Li, G.E. Terry, S.S. Zoghbi, and C. Morse Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers Mol Psychiatry 17 2012 642 649
8. J. Villares Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain Neuroscience 145 2007 323 334
9. D.C. D'Souza, M. Ranganathan, G. Braley, R. Gueorguieva, Z. Zimolo, and T. Cooper Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis Neuropsychopharmacology 33 2008 2505 2516
10. P.T. Nguyen, C.L. Schmid, K.M. Raehal, D.E. Selley, L.M. Bohn, and L.J. Sim-Selley beta-Arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner Biol Psychiatry 71 2012 714 724
11. T.H. Smith, L.J. Sim-Selley, and D.E. Selley Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery Br J Pharmacol 160 2010 454 466
12. M.F. Lazenka, D.E. Selley, and L.J. Sim-Selley Brain regional differences in CB1 receptor adaptation and regulation of transcription Life Sci 92 2013 446 452
13. M.F. Lazenka, D.E. Selley, and L.J. Sim-Selley DeltaFosB induction correlates inversely with CB(1) receptor desensitization in a brain region-dependent manner following repeated Delta(9)-THC administration Neuropharmacology 77 2014 224 233
14. J. Chen, M.B. Kelz, B.T. Hope, Y. Nakabeppu, and E.J. Nestler Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments J Neurosci 17 1997 4933 4941
15. T. Herdegen, and J.D. Leah Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins Brain Res Brain Res Rev 28 1998 370 490
16. E.J. Nestler, M. Barrot, and D.W. Self DeltaFosB: a sustained molecular switch for addiction Proc Natl Acad Sci USA 98 2001 11042 11046
17. E.J. Nestler Review Transcriptional mechanisms of addiction: role of DeltaFosB Philos Trans R Soc Lond B Biol Sci 363 2008 3245 3255
18. M. Werme, C. Messer, L. Olson, L. Gilden, P. Thoren, and E.J. Nestler Delta FosB regulates wheel running J Neurosci 22 2002 8133 8138
19. M.C. Peakman, C. Colby, L.I. Perrotti, P. Tekumalla, T. Carle, and P. Ulery Inducible, brain region-specific expression of a dominant negative mutant of c-Jun in transgenic mice decreases sensitivity to cocaine Brain Res 970 2003 73 86
20. V. Zachariou, C.A. Bolanos, D.E. Selley, D. Theobald, M.P. Cassidy, and M.B. Kelz An essential role for DeltaFosB in the nucleus accumbens in morphine action Nat Neurosci 9 2006 205 211
21. C.A. McClung, and E.J. Nestler Regulation of gene expression and cocaine reward by CREB and DeltaFosB Nat Neurosci 6 2003 1208 1215
22. L.J. Sim-Selley, M.P. Cassidy, A. Sparta, V. Zachariou, E.J. Nestler, and D.E. Selley Effect of DeltaFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbens Neuropharmacology 61 2011 1470 1476
23. J. Chen, M.B. Kelz, G. Zeng, N. Sakai, C. Steffen, and P.E. Shockett Transgenic animals with inducible, targeted gene expression in brain Mol Pharmacol 54 1998 495 503
24. L.J. Sim, D.E. Selley, and S.R. Childers In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5′-[gamma-[35S]thio]-triphosphate binding Proc Natl Acad Sci USA 92 1995 7242 7246
25. P.T. Nguyen, D.E. Selley, and L.J. Sim-Selley Statistical Parametric Mapping reveals ligand and region-specific activation of G-proteins by CB1 receptors and non-CB1 sites in the 3D reconstructed mouse brain Neuroimage 52 2010 1243 1251
26. K.B.J. Franklin, and G. Paxinos The mouse brain in stereotaxic coordinates 2008 Academic Press San Diego, CA
27. 35S]GTPγS autoradiography in rat brain J Neurosci 16 1996 2684 2692
28. K.W. Falenski, A.J. Thorpe, J.E. Schlosburg, B.F. Cravatt, R.A. Abdullah, and T.H. Smith FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration Neuropsychopharmacology 35 2010 1775 1787
29. J.E. Schlosburg, J.L. Blankman, J.Z. Long, D.K. Nomura, B. Pan, and S.G. Kinsey Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system Nat Neurosci 13 2010 1113 1119
30. J.Z. Long, D.K. Nomura, R.E. Vann, D.M. Walentiny, L. Booker, and X. Jin Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo Proc Natl Acad Sci USA 106 2009 20270 20275
31. E.A. McCaw, H. Hu, G.T. Gomez, A.L. Hebb, M.E. Kelly, and E.M. Denovan-Wright Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice Eur J Biochem 271 2004 4909 4920
32. N. Chuhma, K.F. Tanaka, R. Hen, and S. Rayport Functional connectome of the striatal medium spiny neuron J Neurosci 31 2011 1183 1192
33. C.R. Gerfen The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia Annu Rev Neurosci 15 1992 285 320
34. J.D. Lenz, and M.K. Lobo Optogenetic insights into striatal function and behavior Behav Brain Res 255 2013 44 54
35. M.K. Lobo, S. Zaman, D.M. Damez-Werno, J.W. Koo, R.C. Bagot, and J.A. DiNieri DeltaFosB induction in striatal medium spiny neuron subtypes in response to chronic pharmacological, emotional, and optogenetic stimuli J Neurosci 33 2013 18381 18395
36. M.L. Fitzgerald, E. Shobin, and V.M. Pickel Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output Prog Neuropsychopharmacol Biol Psychiatry 38 2012 21 29
37. S. Reagan-Shaw, M. Nihal, and N. Ahmad Dose translation from animal to human studies revisited FASEB J 22 2008 659 661
38. M.A. Huestis, and E.J. Cone Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis J Anal Toxicol 28 2004 394 399
39. A.G. Hohmann, and M. Herkenham Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study Synapse 37 2000 71 80
40. V.M. Pickel, J. Chan, T.L. Kash, J.J. Rodriguez, and K. MacKie Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens Neuroscience 127 2004 101 112
41. K. Monory, H. Blaudzun, F. Massa, N. Kaiser, T. Lemberger, and G. Schutz Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice PLoS Biol 5 2007 e269
42. M. Andersson, A. Usiello, A. Borgkvist, L. Pozzi, C. Dominguez, and A.A. Fienberg Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons J Neurosci 25 2005 8432 8438
43. L.I. Perrotti, R.R. Weaver, B. Robison, W. Renthal, I. Maze, and S. Yazdani Distinct patterns of DeltaFosB induction in brain by drugs of abuse Synapse 62 2008 358 369
44. M.R. Domenici, S.C. Azad, G. Marsicano, A. Schierloh, C.T. Wotjak, and H.U. Dodt Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission J Neurosci 26 2006 5794 5799
45. I. Katona, E.A. Rancz, L. Acsady, C. Ledent, K. Mackie, and N. Hajos Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission J Neurosci 21 2001 9506 9518
46. C. Marie-Claire, I. Laurendeau, C. Canestrelli, C. Courtin, M. Vidaud, and B. Roques Fos but not Cart (cocaine and amphetamine regulated transcript) is overexpressed by several drugs of abuse: a comparative study using real-time quantitative polymerase chain reaction in rat brain Neurosci Lett 345 2003 77 80
47. A. Porcella, G.L. Gessa, and L. Pani Delta9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain Eur J Neurosci 10 1998 1743 1751
48. T. Rubino, D. Vigano, F. Premoli, C. Castiglioni, S. Bianchessi, and R. Zippel Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade Mol Neurobiol 33 2006 199 213
49. G.F. Koob, and N.D. Volkow Neurocircuitry of addiction Neuropsychopharmacology 35 2010 217 238
50. D.J. Morgan, B.J. Davis, C.S. Kearn, D. Marcus, A.J. Cook, and J. Wager-Miller Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice J Neurosci 34 2014 5152 5163